Persomics USA Inc

Qiagen Inc in Waltham is a leading provider of Sample to Insights solutions, empowering customers to extract valuable insights from DNA, RNA, and proteins. The company specializes in delivering innovative tools and technologies that facilitate the analysis and understanding of the fundamental building blocks of life. Generated from their website's infomation

ImmunoGen develops targeted anticancer therapeutics. The company s proprietary Tumor-Activated Prodrug technology uses tumor-targeting antibodies to deliver a potent cell-killing agent specifically to cancer cells. The company uses its technology to develop product candidates. In addition, it licenses the technology to other drug development companies. Companies that have licensed ImmunoGen s technology include Genetech; the Centocor division of Johnson & Johnson; Biogen Idec; sanofi-aventis Group; Boehringer Ingelheim; Milennium Pharmaceuticals; and Abgenix. ImmunoGen is headquartered in Cambridge, Mass., and has a manufacturing facility in Norwood, Mass. The company has more than 170 employees engaged in research and development, clinical research, manufacturing and administrative functions.

Alkermes is a worldwide pharmaceutical company that develops controlled, sustained-release injectable drugs using with its trademark ProLease and Medisorb technologies. Located in Massachusetts, the company also develops inhaled formulations from its proprietary pulmonary technology. Alkermes has partnered with Johnson & Johnson to develop Riserpdal Consta, an antipsychotic drug used in the treatment of schizophrenia. Risperdal Consta is approved for sale in more than 50 countries that include the United States, United Kingdom and Germany. In addition to a host of partnered products, the ocmpany is also active in the development of several promising proprietary products, such as Vivitrex, a long-acting injectable form of naltrexone for alcohol dependence. Alkermes is headquartered in Cambridge, Mass.